Related Experiment Video
Updated: Mar 26, 2026

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
Published on: August 23, 2024
MiRNA-10b sponge: An anti-breast cancer study in vitro
Ai-Ling Liang1, Ting-Ting Zhang2, Ning Zhou1
1Medical Molecular Diagnostics Key Laboratory of Guangdong, and Departments of Biochemistry and Molecular Biology and Clinical Biochemistry, Guangdong Medical University, Dongguan, Guangdong 523808, P.R. China.
Abstract:
Breast cancer is a malignant tumor with the highest incidence among women. Breast cancer metastasis is the major cause of treatment failure and mortality among such patients. MicroRNAs (miRNAs) are a class of small molecular non-coding regulatory RNAs, which act as oncogenes or tumor suppressors in breast cancer. miRNA-10b has been found to exhibit a high expression level in advanced and metastatic breast cancer, and is closely related to breast cancer metastasis. An miRNA sponge is an mRNA with several repeated sequences of complete or incomplete complementarity to the natural miRNA in its 3' non-translating region. It acts as a sponge adsorbing miRNAs and ensures their separation from their targets and inhibits their function. The present study designed a sponge plasmid against miRNA-10b and transiently transfected it into high and low metastatic human breast cancer cell lines MDA-MB-231 and MCF-7, and analyzed the effects of the miRNA-10b sponge on the growth and proliferation, migration and invasion in these cell lines. qRT-PCR results found that the sponge plasmid effectively inhibited the expression of miRNA-10b, and upregulated the expression of the miRNA‑10b target protein HOXD-10. The results from the CCK-8 assay found that the miRNA-10b sponge inhibited the growth of breast cancer cell lines MDA-MB-231 and MCF-7. Results of the plate cloning experiments indicated that the miRNA-10b sponge suppressed the colony formation of the MDA-MB-231 and MCF-7 cells. The results of wound healing and Transwell assays showed that the miRNA-10b sponge inhibited the migration and invasion of the breast cancer cell lines MDA-MB-231 and MCF-7. Our results demonstrated that the miRNA-10b sponge effectively inhibited the growth and proliferation of breast cancer MDA-MB-231 and MCF-7 cells. In addition, it also restrained the migration and invasion of human highly metastatic breast cancer MDA-MB-231 cells.
Insights
A novel miRNA-10b sponge effectively inhibited breast cancer cell growth, proliferation, migration, and invasion. This therapeutic strategy shows promise for treating metastatic breast cancer by targeting miRNA-10b.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Breast cancer metastasis is a primary cause of mortality.
- MicroRNAs (miRNAs), including miRNA-10b, play crucial roles in breast cancer progression and metastasis.
- Targeting oncogenic miRNAs offers a potential therapeutic avenue.
Purpose of the Study:
- To design and evaluate an miRNA-10b sponge for its efficacy in inhibiting breast cancer cell growth, proliferation, migration, and invasion.
- To investigate the effect of the miRNA-10b sponge on HOXD-10 protein expression.
Main Methods:
- Design of a sponge plasmid targeting miRNA-10b.
- Transfection of the sponge plasmid into human breast cancer cell lines (MDA-MB-231 and MCF-7).
- Quantitative real-time PCR (qRT-PCR) for miRNA and protein expression analysis.
- Cell Counting Kit-8 (CCK-8) assay for cell proliferation.
- Plate cloning assay for colony formation.
- Wound healing and Transwell assays for cell migration and invasion.
Main Results:
- The miRNA-10b sponge significantly inhibited miRNA-10b expression and upregulated its target, HOXD-10.
- The sponge suppressed the proliferation and colony formation of both MDA-MB-231 and MCF-7 cells.
- Inhibition of migration and invasion was observed in MDA-MB-231 cells.
Conclusions:
- The designed miRNA-10b sponge effectively inhibits breast cancer cell growth, proliferation, migration, and invasion.
- This miRNA sponge represents a potential therapeutic strategy against metastatic breast cancer.

